Neonatal Acute Kidney Injury due to Maternal Olmesartan Intake: Authors' Reply

Indian J Pediatr. 2024 Nov;91(11):1208. doi: 10.1007/s12098-024-05167-1. Epub 2024 May 27.

Authors

Anish Kumar Saha¹, Phalguni Padhi², Dayanand Hota³, Vinay Rathore⁴

Affiliations

¹ Department of Nephrology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
² Department of Pediatrics, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
³ Department of Pediatrics, Directorate of Health Services, Raipur, Chhattisgarh, India.
⁴ Department of Nephrology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India. vinayrathoremd@gmail.com.

PMID: 38801495
DOI: 10.1007/s12098-024-05167-1

No abstract available

Publication types

Letter

MeSH terms

Acute Kidney Injury* / chemically induced
Angiotensin II Type 1 Receptor Blockers / adverse effects
Antihypertensive Agents / administration & dosage
Antihypertensive Agents / adverse effects
Female
Humans
Imidazoles* / administration & dosage
Imidazoles* / adverse effects
Infant, Newborn
Pregnancy
Tetrazoles* / administration & dosage
Tetrazoles* / adverse effects

Substances

olmesartan
Imidazoles
Tetrazoles
Angiotensin II Type 1 Receptor Blockers
Antihypertensive Agents